Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study
Guangming Cao(Northeastern University), Lei Zhu(Shanghai Changzheng Hospital), Bin Zhang(China National Offshore Oil Corporation (China)), Shuzhen Wang(China Pharmaceutical University), Lina Cui, Shiqing Chen, Zhiqiang Zhang(North Sichuan Medical University), Jinfeng Li(Hebei Medical University), Bei Zhang(Xuzhou Central Hospital), Dingchao Hua(Women's Hospital, School of Medicine, Zhejiang University), Ting Bei(Hua Medicine (China))
Cited by 20
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218